Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolai B Fedorov

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Neuroscience Methods|June 2, 2009
Development and optimization of a high-throughput electrophysiology assay for neuronal alpha4beta2 nicotinic receptorsSerguei S Sidach, Nikolai B Fedorov, Patrick M Lippiello, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 30, 2008
Differential pharmacologies of mecamylamine enantiomers: positive allosteric modulation and noncompetitive inhibitionNikolai B Fedorov, Lisa C Benson, John Graef, et al.
Assay and Drug Development Technologies|August 10, 2016
Electrophysiology-Based Assays to Detect Subtype-Selective Modulation of Human Nicotinic Acetylcholine ReceptorsGlenn E Kirsch, Nikolai B Fedorov, Yuri A Kuryshev, et al.
Current Biology : CB|November 9, 2004
Increased neuronal excitability, synaptic plasticity, and learning in aged Kvbeta1.1 knockout miceGeoffrey G Murphy, Nikolai B Fedorov, K Peter Giese, et al.
Epilepsia|November 23, 2019
Personalized medicine: Vinpocetine to reverse effects of GABRB3 mutationSantoshi Billakota, J Michael Andresen, Bryant C Gay, et al.
Journal of Biomolecular Screening|September 11, 2012
Validation of a high-throughput, automated electrophysiology platform for the screening of nicotinic agonists and antagonistsJohn D Graef, Lisa C Benson, Serguei S Sidach, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 27, 2012
Functional and structural interaction of (-)-reboxetine with the human α4β2 nicotinic acetylcholine receptorHugo R Arias, Nikolai B Fedorov, Lisa C Benson, et al.
Neuron|November 1, 2002
Inhibitory autophosphorylation of CaMKII controls PSD association, plasticity, and learningYpe Elgersma, Nikolai B Fedorov, Sami Ikonen, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 17, 2017
High-Throughput Patch Clamp Screening in Human α6-Containing Nicotinic Acetylcholine ReceptorsLucas C Armstrong, Glenn E Kirsch, Nikolai B Fedorov, et al.
Neuropharmacology|February 2, 2010
Structural differences determine the relative selectivity of nicotinic compounds for native alpha 4 beta 2*-, alpha 6 beta 2*-, alpha 3 beta 4*- and alpha 7-nicotine acetylcholine receptorsSharon R Grady, Ryan M Drenan, Scott R Breining, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Neuroscience Methods|June 2, 2009
Development and optimization of a high-throughput electrophysiology assay for neuronal alpha4beta2 nicotinic receptorsSerguei S Sidach, Nikolai B Fedorov, Patrick M Lippiello, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 30, 2008
Differential pharmacologies of mecamylamine enantiomers: positive allosteric modulation and noncompetitive inhibitionNikolai B Fedorov, Lisa C Benson, John Graef, et al.
Assay and Drug Development Technologies|August 10, 2016
Electrophysiology-Based Assays to Detect Subtype-Selective Modulation of Human Nicotinic Acetylcholine ReceptorsGlenn E Kirsch, Nikolai B Fedorov, Yuri A Kuryshev, et al.
Current Biology : CB|November 9, 2004
Increased neuronal excitability, synaptic plasticity, and learning in aged Kvbeta1.1 knockout miceGeoffrey G Murphy, Nikolai B Fedorov, K Peter Giese, et al.
Epilepsia|November 23, 2019
Personalized medicine: Vinpocetine to reverse effects of GABRB3 mutationSantoshi Billakota, J Michael Andresen, Bryant C Gay, et al.
Journal of Biomolecular Screening|September 11, 2012
Validation of a high-throughput, automated electrophysiology platform for the screening of nicotinic agonists and antagonistsJohn D Graef, Lisa C Benson, Serguei S Sidach, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 27, 2012
Functional and structural interaction of (-)-reboxetine with the human α4β2 nicotinic acetylcholine receptorHugo R Arias, Nikolai B Fedorov, Lisa C Benson, et al.
Neuron|November 1, 2002
Inhibitory autophosphorylation of CaMKII controls PSD association, plasticity, and learningYpe Elgersma, Nikolai B Fedorov, Sami Ikonen, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 17, 2017
High-Throughput Patch Clamp Screening in Human α6-Containing Nicotinic Acetylcholine ReceptorsLucas C Armstrong, Glenn E Kirsch, Nikolai B Fedorov, et al.
Neuropharmacology|February 2, 2010
Structural differences determine the relative selectivity of nicotinic compounds for native alpha 4 beta 2*-, alpha 6 beta 2*-, alpha 3 beta 4*- and alpha 7-nicotine acetylcholine receptorsSharon R Grady, Ryan M Drenan, Scott R Breining, et al.
Pageof 2